Insight Molecular DiagnosticIMDX
13F holders, Q2 2026 (June 30)40holders −1
11new positions
13sold out
1famous investor
$5.90avg. 13F price*
At the end of Q2 2026, 40 institutions reported holding Insight Molecular Diagnostic (IMDX) in their 13F filings, down 1 from Q1 2026. 11 opened new positions and 13 sold out. The largest holders were Broadwood Capital Inc. ($74.8M), AWM Investment Company, Inc. ($16.7M) and Vanguard Capital Management LLC ($4.3M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Insight Molecular Diagnostic
- CUSIP
- 68235C206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $1.4M |
| Exits | 13 | $4.8M |
All 13F filers, Q1 2026 → Q2 2026: 1,567,491 shares bought and 2,041,181 shares sold, net −473,690 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| Broadwood Capital Inc. | 3.91% | Add +6.3% | 12,684,884 | $74.8M |
| AWM Investment Company, Inc. | 1.45% | Add +1.1% | 2,836,692 | $16.7M |
| Vanguard Capital Management LLC | 0.00% | Add +37.0% | 735,847 | $4.3M |
| Pura Vida Investments, LLC | 7.73% | Reduce -48.8% | 484,845 | $2.9M |
| Family Office Research LLC | 0.82% | Add +189.8% | 368,849 | $2.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 256,903 | $1.5M |
| FNY Investment Advisers, LLC | 0.39% | Reduce -26.2% | 182,561 | $1.1M |
| Jane Street Group, LLC | 0.00% | New | 157,682 | $930K |
| BlackRock, Inc. | 0.00% | Add +11.2% | 150,521 | $888K |
| Vanguard Fiduciary Trust Co. | 0.00% | Reduce -6.0% | 124,576 | $735K |
| State Street Corp. | 0.00% | Add +81.5% | 92,124 | $544K |
| Millennium Management | 0.00% | Reduce -20.3% | 82,499 | $487K |
| UBS Group AG | 0.00% | Add +134.2% | 53,276 | $314K |
| Northern Trust Corp. | 0.00% | No change | 49,090 | $290K |
| Osaic Holdings, Inc. | 0.00% | Add +62.1% | 39,136 | $231K |
| Morgan Stanley | 0.00% | Reduce -1.6% | 35,515 | $210K |
| Jefferies Financial Group Inc. | 0.00% | New | 18,100 | $107K |
| Marshall Wace, LLP | 0.00% | New | 16,597 | $98K |
| ExodusPoint Capital Management, LP | 0.00% | New | 14,029 | $83K |
| Axq Capital, LP | 0.01% | New | 13,407 | $79K |
| Flatrock Wealth Partners LLC | 0.03% | No change | 13,044 | $77K |
| Two Sigma Investments, LP | 0.00% | New | 11,101 | $65K |
| XTX Topco Ltd | 0.00% | Reduce -64.6% | 10,743 | $63K |
| Private Advisor Group, LLC | 0.00% | No change | 10,416 | $61K |
| BNP Paribas Financial Markets | 0.00% | Add +8964.1% | 5,801 | $34K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 5,775 | $34K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 5,000 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,691 | $16K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 1,960 | $12K |
| SBI Securities Co., Ltd. | 0.00% | No change | 185 | $1K |
| Royal Bank of Canada | 0.00% | New | 251 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 154 | $835 |
| Jones Financial Companies LLLP | 0.00% | New | 63 | $340 |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +4400.0% | 45 | $266 |
| Piscataqua Savings Bank | 0.00% | No change | 25 | $147 |
| Albion Financial Group | 0.00% | No change | 7 | $42 |
| Wells Fargo & Company | 0.00% | New | 7 | $41 |
| Cassaday & Co Wealth Management LLC | 0.00% | Reduce -40.0% | 6 | $36 |
| Global Retirement Partners, LLC | 0.00% | — | 1 | $6 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is IMDX's weight in each manager's 13F, not the share of Insight Molecular Diagnostic the manager owns.